152 related articles for article (PubMed ID: 3514341)
21. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
[TBL] [Abstract][Full Text] [Related]
22. Cytoplasmic islet cell antibodies in children with type I diabetes.
Michalková D; Kostál M; Rajcáni J; Petrovicová A; Bircák J; Kolár J; Barák L; Hrabcáková D
Bratisl Lek Listy; 1989 Mar; 90(3):159-67. PubMed ID: 2541873
[TBL] [Abstract][Full Text] [Related]
23. [Autoimmunity and viral infections in type-I diabetes mellitus].
Helmke K; Weimer R; Willems W; Otten A; Mäser E; Velcovsky HG; Federlin K
Dtsch Med Wochenschr; 1986 Mar; 111(10):369-73. PubMed ID: 3512225
[TBL] [Abstract][Full Text] [Related]
24. Role of antecedent mumps and reovirus infections on the development of type 1 (insulin-dependent) diabetes.
Toniolo A; Conaldi PG; Garzelli C; Benedettini G; Federico G; Saggese G; Vettor R; Federspil G
Eur J Epidemiol; 1985 Sep; 1(3):172-9. PubMed ID: 3021516
[TBL] [Abstract][Full Text] [Related]
25. No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study.
Hummel M; Füchtenbusch M; Schenker M; Ziegler AG
Diabetes Care; 2000 Jul; 23(7):969-74. PubMed ID: 10895848
[TBL] [Abstract][Full Text] [Related]
26. Influenza A virus antibodies show no association with pancreatic islet autoantibodies in children genetically predisposed to type 1 diabetes.
Kondrashova A; Nurminen N; Patrikainen M; Huhtala H; Lehtonen J; Toppari J; Ilonen J; Simell OG; Veijola R; Knip M; Hyöty H
Diabetologia; 2015 Nov; 58(11):2592-5. PubMed ID: 26253765
[TBL] [Abstract][Full Text] [Related]
27. Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes.
Spencer KM; Tarn A; Dean BM; Lister J; Bottazzo GF
Lancet; 1984 Apr; 1(8380):764-6. PubMed ID: 6143085
[TBL] [Abstract][Full Text] [Related]
28. Virus genotypes and responses of serum-specific antibodies in children with primary mumps and mumps reinfection.
Sakata R; Nagita A; Kidokoro M; Kato A; Ogino K
Pediatr Res; 2015 Nov; 78(5):580-4. PubMed ID: 26267156
[TBL] [Abstract][Full Text] [Related]
29. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
Mustonen A; Knip M; Akerblom HK
Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
[TBL] [Abstract][Full Text] [Related]
30. Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies.
Mustonen A; Knip M; Huttunen NP; Puukka R; Käär ML; Akerblom HK
Diabetologia; 1984 Oct; 27(4):421-6. PubMed ID: 6391985
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of various types of islet cell antibodies in diabetes as a function of its cause and duration].
Vialettes B; Di Campo-Rougerie C; Lassmann V; Vague P
Presse Med; 1983 Oct; 12(37):2303-6. PubMed ID: 6226978
[TBL] [Abstract][Full Text] [Related]
32. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
[TBL] [Abstract][Full Text] [Related]
33. In vitro inhibition of insulin release mediated by sera with complement-fixing islet cell antibodies belonging to normal first degree relatives of patients with type 1 diabetes.
Sensi M; Zuccarini O; Spencer KM; Beales P; Pujol-Borrell R; Pozzilli P
Diabetes Res; 1985 Jan; 2(1):1-4. PubMed ID: 3888494
[TBL] [Abstract][Full Text] [Related]
34. Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabetes.
Bruining GJ; Molenaar J; Tuk CW; Lindeman J; Bruining HA; Marner B
Diabetologia; 1984 Jan; 26(1):24-9. PubMed ID: 6368297
[TBL] [Abstract][Full Text] [Related]
35. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
[TBL] [Abstract][Full Text] [Related]
36. A prospective analysis of antibodies reacting with pancreatic islet cells in insulin-dependent diabetic children.
Lernmark A; Hägglöf B; Freedman Z; Irvine J; Ludvigsson J; Holmgren G
Diabetologia; 1981 Apr; 20(4):471-4. PubMed ID: 7016642
[TBL] [Abstract][Full Text] [Related]
37. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
Gleichmann H; Zörcher B; Greulich B; Gries FA; Henrichs HR; Betrams J; Kolb H
Diabetologia; 1984 Jul; 27 Suppl():90-2. PubMed ID: 6383926
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of islet cell antibodies.
Lipton R; LaPorte RE
Epidemiol Rev; 1989; 11():182-203. PubMed ID: 2680555
[TBL] [Abstract][Full Text] [Related]
39. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method.
Kobayashi T; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S; Sato K; Tsuji K
Diabetes; 1986 Mar; 35(3):335-40. PubMed ID: 3512344
[TBL] [Abstract][Full Text] [Related]
40. Prospective analysis of islet cell antibodies in children with type 1 (insulin-dependent) diabetes.
Kolb H; Dannehl K; Grüneklee D; Zielasek J; Bertrams J; Hübinger A; Gries FA
Diabetologia; 1988 Apr; 31(4):189-94. PubMed ID: 3290017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]